Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
QuintilesIMS
Moodys
Daiichi Sankyo
Citi
UBS
Healthtrust
Baxter

Generated: April 23, 2018

DrugPatentWatch Database Preview

Profile for United Kingdom Patent: 0304822

« Back to Dashboard

US Patent Family Members and Approved Drugs for United Kingdom Patent: 0304822

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
➤ Try a Free Trial Sep 23, 2027 Sanofi Aventis Us APIDRA SOLOSTAR insulin glulisine recombinant
➤ Try a Free Trial Sep 23, 2027 Sanofi-aventis Us ADMELOG SOLOSTAR insulin lispro
➤ Try a Free Trial Sep 23, 2027 Sanofi-aventis Us SOLIQUA 100/33 insulin glargine; lixisenatide
➤ Try a Free Trial Sep 23, 2027 Sanofi Us Services TOUJEO MAX SOLOSTAR insulin glargine recombinant
US Patent Number US Expiration Date US Applicant US Tradename Generic Name

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Accenture
Boehringer Ingelheim
Merck
Covington
Mallinckrodt
Baxter
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.